Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: a multicentre US study. (åpner nytt vindu)

Al-Samkari H, Jiang D, Gernsheimer T, Liebman H, Lee S, Wojdyla M, Vredenburg M, Cuker A

Kilde‎: Br J Haematol. 2022;197(3):359-66.

Arkiv‎: PubMed 35179784

DOI‎: 10.1111/bjh.18081

https://pubmed.ncbi.nlm.nih.gov/35179784/ (åpner nytt vindu)

Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with idiopathic thrombocytopenic purpura. (åpner nytt vindu)

Alpdogan O, Budak-Alpdogan T, Ratip S, Firatli-Tuglular T, Tanriverdi S, Karti S, Bayik M, Akoglu T.

Kilde‎: Br J Haematol 1998;103(4):1061-3.

Arkiv‎: PubMed 9886319

https://www.ncbi.nlm.nih.gov/pubmed/9886319 (åpner nytt vindu)

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. (åpner nytt vindu)

Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, Fraser GA, Lim W, Kelton JG.

Kilde‎: Ann Intern Med 2007;146(1):25-33.

Arkiv‎: PubMed 17200219

https://www.ncbi.nlm.nih.gov/pubmed/17200219 (åpner nytt vindu)

Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. (åpner nytt vindu)

Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Amini S, Schipperus M, Lim W, Vishnu P, Warner M, Carruthers J, Li N, Lane S, Kelton JG

Kilde‎: Lancet Haematol 2020;7(9):e640-8.

Arkiv‎: PubMed 32853584

DOI‎: 10.1016/S2352-3026(20)30227-1

https://www.ncbi.nlm.nih.gov/pubmed/32853584 (åpner nytt vindu)

A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. (åpner nytt vindu)

Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D, de Veber B, Gent M.

Kilde‎: J Pediatr 1993;123(6):989-95.

Arkiv‎: PubMed 8229536

https://www.ncbi.nlm.nih.gov/pubmed/8229536 (åpner nytt vindu)

High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. (åpner nytt vindu)

Borst F, Keuning JJ, van Hulsteijn H, Sinnige H, Vreugdenhil G.

Kilde‎: Ann Hematol 2004;83(12):764-8.

Arkiv‎: PubMed 15309522

DOI‎: 10.1007/s00277-004-0908-1

https://www.ncbi.nlm.nih.gov/pubmed/15309522 (åpner nytt vindu)

Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. (åpner nytt vindu)

British Committee for Standards in Haematology General Haematology Task Force.

Kilde‎: Br J Haematol 2003;120(4):574-96.

Arkiv‎: PubMed 12588344

https://www.ncbi.nlm.nih.gov/pubmed/12588344 (åpner nytt vindu)

IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP. (åpner nytt vindu)

Carcao M, Silva M, David M, Klaassen RJ, Steele M, Price V, Wakefield C, Kim L, Stephens D, Blanchette VS

Kilde‎: Blood Adv 2020;4(7):1492-1500.

Arkiv‎: PubMed 32282882

DOI‎: 10.1182/bloodadvances.2019001343

https://www.ncbi.nlm.nih.gov/pubmed/32282882 (åpner nytt vindu)

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. (åpner nytt vindu)

Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, Wong WS, Cheng G.

Kilde‎: N Engl J Med 2003;349(9):831-6.

Arkiv‎: PubMed 12944568

DOI‎: 10.1056/NEJMoa030254

https://www.ncbi.nlm.nih.gov/pubmed/12944568 (åpner nytt vindu)

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. (åpner nytt vindu)

Ghanima W, Godeau B, Cines DB, Bussel JB.

Kilde‎: Blood 2012;120(5):960-9.

Arkiv‎: PubMed 22740443

DOI‎: 10.1182/blood-2011-12-309153

https://www.ncbi.nlm.nih.gov/pubmed/22740443 (åpner nytt vindu)

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice. (åpner nytt vindu)

González-López TJ, Alvarez-Román MT, Pascual C, Sánchez-González B, Fernández-Fuentes F, Pérez-Rus G, Hernández-Rivas JA, Bernat S, Bastida JM, Martínez-Badas MP, Martínez-Robles V, Soto I, Olivera P, Bolaños E, Alonso R, Entrena L, Gómez-Nuñez M, Alonso A, Yera Cobo M, Caparrós I, Tenorio M, Arrieta-Cerdán E, Lopez-Ansoar E, García-Frade J, González-Porras JR

Kilde‎: Br J Haematol 2017;178(6):959-70.

Arkiv‎: PubMed 28573819

DOI‎: 10.1111/bjh.14788

https://www.ncbi.nlm.nih.gov/pubmed/28573819 (åpner nytt vindu)

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. (åpner nytt vindu)

Kojouri K, Vesely SK, Terrell DR, George JN.

Kilde‎: Blood 2004;104(9):2623-34.

Arkiv‎: PubMed 15217831

DOI‎: 10.1182/blood-2004-03-1168

https://www.ncbi.nlm.nih.gov/pubmed/15217831 (åpner nytt vindu)

Romiplostim or standard of care in patients with immune thrombocytopenia. (åpner nytt vindu)

Kuter DJ, Rummel M, Boccia R, Macik BG, Pabinger I, Selleslag D, Rodeghiero F, Chong BH, Wang X, Berger DP.

Kilde‎: N Engl J Med 2010;363(20):1889-99.

Arkiv‎: PubMed 21067381

DOI‎: 10.1056/NEJMoa1002625

https://www.ncbi.nlm.nih.gov/pubmed/21067381 (åpner nytt vindu)

Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. (åpner nytt vindu)

Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, Vianelli N, Avvisati G, Rodeghiero F, Amendola A, Baronci C, Carbone C, Quattrin S, Fioritoni G, D'Alfonso G, Mandelli F; Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Thrombocytopenia Working Party.

Kilde‎: Blood 2007;109(4):1401-7.

Arkiv‎: PubMed 17077333

DOI‎: 10.1182/blood-2005-12-015222

https://www.ncbi.nlm.nih.gov/pubmed/17077333 (åpner nytt vindu)

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. (åpner nytt vindu)

Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology.

Kilde‎: Blood 2011;117(16):4190-207.

Arkiv‎: PubMed 21325604

DOI‎: 10.1182/blood-2010-08-302984

https://www.ncbi.nlm.nih.gov/pubmed/21325604 (åpner nytt vindu)

American Society of Hematology 2019 guidelines for immune thrombocytopenia. (åpner nytt vindu)

Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kühne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK

Kilde‎: Blood Adv 2019;3(23):3829-66.

Arkiv‎: PubMed 31794604

DOI‎: 10.1182/bloodadvances.2019000966

https://www.ncbi.nlm.nih.gov/pubmed/31794604 (åpner nytt vindu)

International consensus report on the investigation and management of primary immune thrombocytopenia. (åpner nytt vindu)

Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ.

Kilde‎: Blood 2010;115(2):168-86.

Arkiv‎: PubMed 19846889

DOI‎: 10.1182/blood-2009-06-225565

https://www.ncbi.nlm.nih.gov/pubmed/19846889 (åpner nytt vindu)

Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. (åpner nytt vindu)

Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB.

Kilde‎: Blood 1997;89(8):2689-700.

Arkiv‎: PubMed 9108386

https://www.ncbi.nlm.nih.gov/pubmed/9108386 (åpner nytt vindu)